Effect of Propolis Application on Burn Healing
Effect of Topical Turkish Propolis Application on Burn Healing in Experimental Burn Model
1 other identifier
interventional
36
1 country
1
Brief Summary
This experimental study will be carried out at Ege University Laboratory Animals Application and Research Center to identify the efficacy of 10% propolis and 15% propolis on wound healing in a second-degree superficial burn wound. In the study, 36 adult (8-12 week old) Wistar-Albino rats with a weight of 200-300 grams will be used in each group. Each group will include 6 rats. Stratified randomization will be used to randomize rats according to their gender and weight. After randomization, a burnt area will be created on the back of the rats and dressings will be made every day. Following the creation of the burn, biopsy samples will be taken on the 3rd, 7th, 14th and 21st days and at the light microscopic level; bulla, erythema, oedema, burn depth, inflammatory cell infiltration, necrosis, ulceration, angiogenesis, neovascularization, fibroblast proliferation, collagenization, epithelization, fibrosis, the number of hair follicles and damage to the skin attachments. In the immunohistochemical examination of biopsy samples, samples will be taken for the evaluation of superoxide dismutase, malondialdehyde, myeloperoxidase in the evaluation of the tumour necrosis factor-alpha, interleukin-1β and oxidative stress in the EBB period in order to evaluate the acute phase reactants. Fungal and gram staining will be done in order to determine the pathogen reproduction in biopsy samples taken on the 3rd and 7th day. Masson trichrome in order to detect fibrosis in biopsy samples taken on the 14th and 21st day; Hydroxyproline examination will be examined in order to evaluate collagen formation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2020
CompletedFirst Posted
Study publicly available on registry
February 20, 2020
CompletedStudy Start
First participant enrolled
September 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 28, 2020
CompletedAugust 3, 2022
August 1, 2022
27 days
February 17, 2020
August 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (41)
wound size
photos will be taken every day to determine the wound size
21 days
bulla
examination of the skin at the light microscopic level. Bulla will be considered as present or absent.
3rd day of the research
bulla
examination of the skin at the light microscopic level. Bulla will be considered as present or absent.
7th day of the research
bulla
examination of the skin at the light microscopic level. Bulla will be considered as present or absent.
14th day of the research
bulla
examination of the skin at the light microscopic level. Erythemawill be considered as present or absent.
21st day day of the research
edema
examination of the skin at the light microscopic level. Edema will be considered as present or absent.
3rd day of the research
edema
examination of the skin at the light microscopic level. Edema will be considered as present or absent.
7th day of the research
edema
examination of the skin at the light microscopic level. Edema will be considered as present or absent.
14th day of the research
edema
examination of the skin at the light microscopic level. Edema will be considered as present or absent.
21st day of the research
inflammatory cell infiltration
examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.
3rd day of the research
inflammatory cell infiltration
examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.
7th day of the research
inflammatory cell infiltration
examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.
14th day of the research
inflammatory cell infiltration
examination of the skin at the light microscopic level. Inflammatory cell infiltration will be considered as present or absent.
21st day of the research
necrosis
examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.
3rd day of the research
necrosis
examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.
7th day of the research
necrosis
examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.
14th day of the research
necrosis
examination of the skin at the light microscopic level. Necrosis will be considered as present or absent.
21st day of the research
ulceration
examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.
3rd day of the research
ulceration
examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.
7th day of the research
ulceration
examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.
14th day of the research
ulceration
examination of the skin at the light microscopic level. Ulceration will be considered as present or absent.
21st day of the research
angiogenesis
examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.
3rd day of the research
angiogenesis
examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.
7th day of the research
angiogenesis
examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.
14th day of the research
angiogenesis
examination of the skin at the light microscopic level. Angiogenesis will be considered as present or absent.
21st day of the research
fibroblast proliferation
examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.
3rd day of the research
fibroblast proliferation
examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.
7th day of the research
fibroblast proliferation
examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.
14th day of the research
fibroblast proliferation
examination of the skin at the light microscopic level. Fibroblast proliferation will be considered as present or absent.
21st day of the research
epithelization
examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.
3rd day of the research
epithelization
examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.
7th day of the research
epithelization
examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.
14th day of the research
epithelization
examination of the skin at the light microscopic level. Epithelization will be considered as present or absent.
21st day of the research
collagenization
examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.
3rd day of the research
collagenization
examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.
7th day of the research
collagenization
examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.
14th day of the research
collagenization
examination of the skin at the light microscopic level. Collagenization will be considered as present or absent.
21st day of the research
microorganism colonization
examination of the skin at the light microscopic level. Colonization will be considered as present or absent.
3rd day of the research
microorganism colonization
examination of the skin at the light microscopic level. Colonization will be considered as present or absent.
7th day of the research
microorganism colonization
examination of the skin at the light microscopic level. Colonization will be considered as present or absent.
14th day of the research
microorganism colonization
examination of the skin at the light microscopic level. Colonization will be considered as present or absent.
21st day of the research
Study Arms (6)
Control group
PLACEBO COMPARATORIt will be accepted as the control group and 4 experimental burn wounds will be created on the back of the rats in the group and no treatment will be given.
1% Silver Sulfadiazine
ACTIVE COMPARATOR4 experimental burn wounds will be created on the back of the rats in the group and dressing with 1% Silver Sulfadiazine will be done on the back of the rats every day for 21 days.
%0.2 Nitrafurozon
ACTIVE COMPARATOR4 experimental burn wounds will be created on the back of the rats in the group and dressing with %0.2 Nitrafurozon will be done on the back of the rats every day for 21 days.
10% Propolis
EXPERIMENTAL4 experimental burn wounds will be created on the back of the rats in the group and dressing with 10% Propolis will be done on the back of the rats every day for 21 days.
15% Propolis
EXPERIMENTAL4 experimental burn wounds will be created on the back of the rats in the group and dressing with 15% Propolis will be done on the back of the rats every day for 21 days.
Propolis vehicle
ACTIVE COMPARATOR4 experimental burn wounds will be created on the back of the rats in the group and dressing with Propolis vehicle will be done on the back of the rats every day for 21 days.
Interventions
1. st. group: It will be considered as a control group and rats will not be treated. 2. nd. group: Vehicle group, Propolis vehicle will be applied topically to rats for 21 days. 3. rd group: Silver Sulfadiazine group, 1% Silver Sulfadiazine will be applied topically to rats for 21 days. 4. th. group: Nitrafurozon group, 0.2% Nitrafurozon will be applied topically for 21 days. 5. th. group: 10% Propolis group, 10% Propolis will be applied topically for 21 days. 6. th. group: 15% Propolis group, 15% Propolis will be applied topically for 21 days.
Eligibility Criteria
You may qualify if:
- adult (8-12 weeks)
- grams
- Wistar-Albino rat
- with 4 second-degree superficial contact burn are at its back.
You may not qualify if:
- the death of the rat in the research process
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ege University
Izmir, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Figen Yardımcı
Ege University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the researcher who will analyze the primary outcome of the study will not know which group of animals the samples were taken from.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
February 17, 2020
First Posted
February 20, 2020
Study Start
September 1, 2020
Primary Completion
September 28, 2020
Study Completion
September 28, 2020
Last Updated
August 3, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share
the study's data is planned to be published and shared in a scientific paper